merck glp 1 agonist Comparing Ozempic, Wegovy and Other GLP-1 Drugs Merck pays $112M upfront for
Description
Testosterone therapy induces molecular programming augmenting physiological adaptations to resistance exercise in older men
Project administration: HSK
As use of these drugs is expected to expand to other health conditions, there is a pressing need for physical therapists to adapt their practices to support the long-term health goals of their patients and ensure optimal patient outcomes
Future studies will need to address these issues and improve GLP-1 therapies for older adults
